Thulium laser enucleation of the prostate (ThuLEP): Results, complications, and risk factors in 139 consecutive cases
Objectives: To report our experience with the emerging technique of thulium laser enucleation of the prostate (ThuLEP) for the treatment for prostate hyperplasia. Patients and methods: Our inclusion criteria were an International Prostate Symptom Score (IPSS) of >15 and a quality-of-life (QoL) sc...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f5a14f77cf5d4dcdbf44bc3bbb3cb09b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f5a14f77cf5d4dcdbf44bc3bbb3cb09b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f5a14f77cf5d4dcdbf44bc3bbb3cb09b2021-12-02T13:03:31ZThulium laser enucleation of the prostate (ThuLEP): Results, complications, and risk factors in 139 consecutive cases2090-598X10.1016/j.aju.2018.05.004https://doaj.org/article/f5a14f77cf5d4dcdbf44bc3bbb3cb09b2018-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2090598X18300603https://doaj.org/toc/2090-598XObjectives: To report our experience with the emerging technique of thulium laser enucleation of the prostate (ThuLEP) for the treatment for prostate hyperplasia. Patients and methods: Our inclusion criteria were an International Prostate Symptom Score (IPSS) of >15 and a quality-of-life (QoL) score of >3 in patients with confirmed bladder outflow obstruction, no longer responsive to medical therapy, with a significant post-void residual urine volume (PVR; >100 mL), with or without recurrent urinary tract infection and/or acute urinary retention. Patients with neurogenic bladder, urethral strictures, bladder stones, and previously failed transurethral prostate surgery were excluded. Results: In all, 139 men were included in the study. The mean age was 67.8 years. The IPSS and QoL score improved by 17.6 and 2.6, respectively. The flow rate increased from a mean of 9.6 mL to 31.2 mL and the PVR decreased from a mean of 131 mL to 30 mL. On univariate and multivariate analyses, operating time was a predictive factor for haemoglobin drop during the operation. Heparin prophylaxis was the only risk factor identified for postoperative bleeding. Two patients (0.01%) required blood transfusion. One patient (0.007%) required re-intervention for bleeding control, and two patients developed urethral and bladder neck strictures (0.01%). Conclusion: ThuLEP is safe and reproducible. Whilst it significantly reduces intraoperative bleeding as compared to transurethral resection of the prostate, operating time and perioperative heparin prophylaxis may still lead to a Hb drop and constitute a risk factor for postoperative bleeding. Therefore, a potential risk of deep vein thrombosis requiring heparin prophylaxis should be carefully considered and balanced with the expected clinical benefit of the operation. Keywords: Prostate enlargement, Thulium laser, Endoscopy, TreatmentMarco RaberNoor N.P. BuchholzAugusto VercesiNashaat A. HendawiVincenzo InneoGiuseppe Di PaolaLorenzo TessaIsmail M. HassanTaylor & Francis GrouparticleDiseases of the genitourinary system. UrologyRC870-923ENArab Journal of Urology, Vol 16, Iss 4, Pp 411-416 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Diseases of the genitourinary system. Urology RC870-923 |
spellingShingle |
Diseases of the genitourinary system. Urology RC870-923 Marco Raber Noor N.P. Buchholz Augusto Vercesi Nashaat A. Hendawi Vincenzo Inneo Giuseppe Di Paola Lorenzo Tessa Ismail M. Hassan Thulium laser enucleation of the prostate (ThuLEP): Results, complications, and risk factors in 139 consecutive cases |
description |
Objectives: To report our experience with the emerging technique of thulium laser enucleation of the prostate (ThuLEP) for the treatment for prostate hyperplasia. Patients and methods: Our inclusion criteria were an International Prostate Symptom Score (IPSS) of >15 and a quality-of-life (QoL) score of >3 in patients with confirmed bladder outflow obstruction, no longer responsive to medical therapy, with a significant post-void residual urine volume (PVR; >100 mL), with or without recurrent urinary tract infection and/or acute urinary retention. Patients with neurogenic bladder, urethral strictures, bladder stones, and previously failed transurethral prostate surgery were excluded. Results: In all, 139 men were included in the study. The mean age was 67.8 years. The IPSS and QoL score improved by 17.6 and 2.6, respectively. The flow rate increased from a mean of 9.6 mL to 31.2 mL and the PVR decreased from a mean of 131 mL to 30 mL. On univariate and multivariate analyses, operating time was a predictive factor for haemoglobin drop during the operation. Heparin prophylaxis was the only risk factor identified for postoperative bleeding. Two patients (0.01%) required blood transfusion. One patient (0.007%) required re-intervention for bleeding control, and two patients developed urethral and bladder neck strictures (0.01%). Conclusion: ThuLEP is safe and reproducible. Whilst it significantly reduces intraoperative bleeding as compared to transurethral resection of the prostate, operating time and perioperative heparin prophylaxis may still lead to a Hb drop and constitute a risk factor for postoperative bleeding. Therefore, a potential risk of deep vein thrombosis requiring heparin prophylaxis should be carefully considered and balanced with the expected clinical benefit of the operation. Keywords: Prostate enlargement, Thulium laser, Endoscopy, Treatment |
format |
article |
author |
Marco Raber Noor N.P. Buchholz Augusto Vercesi Nashaat A. Hendawi Vincenzo Inneo Giuseppe Di Paola Lorenzo Tessa Ismail M. Hassan |
author_facet |
Marco Raber Noor N.P. Buchholz Augusto Vercesi Nashaat A. Hendawi Vincenzo Inneo Giuseppe Di Paola Lorenzo Tessa Ismail M. Hassan |
author_sort |
Marco Raber |
title |
Thulium laser enucleation of the prostate (ThuLEP): Results, complications, and risk factors in 139 consecutive cases |
title_short |
Thulium laser enucleation of the prostate (ThuLEP): Results, complications, and risk factors in 139 consecutive cases |
title_full |
Thulium laser enucleation of the prostate (ThuLEP): Results, complications, and risk factors in 139 consecutive cases |
title_fullStr |
Thulium laser enucleation of the prostate (ThuLEP): Results, complications, and risk factors in 139 consecutive cases |
title_full_unstemmed |
Thulium laser enucleation of the prostate (ThuLEP): Results, complications, and risk factors in 139 consecutive cases |
title_sort |
thulium laser enucleation of the prostate (thulep): results, complications, and risk factors in 139 consecutive cases |
publisher |
Taylor & Francis Group |
publishDate |
2018 |
url |
https://doaj.org/article/f5a14f77cf5d4dcdbf44bc3bbb3cb09b |
work_keys_str_mv |
AT marcoraber thuliumlaserenucleationoftheprostatethulepresultscomplicationsandriskfactorsin139consecutivecases AT noornpbuchholz thuliumlaserenucleationoftheprostatethulepresultscomplicationsandriskfactorsin139consecutivecases AT augustovercesi thuliumlaserenucleationoftheprostatethulepresultscomplicationsandriskfactorsin139consecutivecases AT nashaatahendawi thuliumlaserenucleationoftheprostatethulepresultscomplicationsandriskfactorsin139consecutivecases AT vincenzoinneo thuliumlaserenucleationoftheprostatethulepresultscomplicationsandriskfactorsin139consecutivecases AT giuseppedipaola thuliumlaserenucleationoftheprostatethulepresultscomplicationsandriskfactorsin139consecutivecases AT lorenzotessa thuliumlaserenucleationoftheprostatethulepresultscomplicationsandriskfactorsin139consecutivecases AT ismailmhassan thuliumlaserenucleationoftheprostatethulepresultscomplicationsandriskfactorsin139consecutivecases |
_version_ |
1718393542487834624 |